News

Galderma Initiates Two New Clinical Trials Investigating Nemolizumab in Patients With Systemic Sclerosis and Chronic Pruritus of Unknown Origin ...
Subjects in the trial saw clearance or near-clearance of skin nodules, as measured by the Investigator’s Global Assessment score.
to treat adults with prurigo nodularis (PN). It is not known if DUPIXENT is safe and effective in children with PN under 18 years of age.
LONDON, GREATER LONDON, UNITED KINGDOM, June 19, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...
Galderma’s Nemluvio (nemolizumab) has demonstrated sustained and clinically meaningful improvements in the key signs and ...
The global market for prurigo nodularis treatment has witnessed substantial growth in recent years and is projected to grow from $1.64 billion in 2024 to $1.73 billion in 2025 at a compound annual ...
The global prurigo nodularis market is surging due to rising prevalence, increased awareness, and treatment innovations. Key drivers include advanced biologic therapies like dupilumab, addressing ...
The global prurigo nodularis market is surging due to rising prevalence, increased awareness, and treatment innovations. Key drivers include advanced biologic therapies like dupilumab, addressing ...
Prurigo nodularis is a chronic skin condition that causes intensely itchy bumps. These hard lumps, called nodules, often appear on areas you can easily scratch, like your arms, legs, and upper back.
Prurigo nodularis is estimated to affect up to 181,000 people in the US and is characterised by intense itch and thick skin nodules covering large body areas. Nemluvio is designed to address the ...
Dermatologists and other researchers are still studying what causes this disease. From what researchers have found, we know that the following play a role in causing prurigo nodularis: Nerves become ...
Introduction Prurigo is a reactive hyperplastic skin condition characterized by papules, plaques, and/or nodules, either isolated or multiple, with intense pruritus. Some authors classify prurigo ...